Evidence map›Paper›PMID 20824482›Full record

SynthesisSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2010

The Fatigue Symptom Inventory: a systematic review of its psychometric properties.

Kristine A Donovan, Paul B Jacobsen

Registry-linked trialAbstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04622293 (A Double-Blind, Randomized, Placebo-Controlled, Single-Center, Flexible Titration Study Evaluating the Efficacy of Solriamfetol in Treating Fatigue and Cognitive Symptoms in Adults Aged 18-65 Years With a Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome), which is not on this map. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04622293 phase4completednot on this mapstarted 2021, after this paper: background citation

A Double-Blind, Randomized, Placebo-Controlled, Single-Center, Flexible Titration Study Evaluating the Efficacy of Solriamfetol in Treating Fatigue and Cognitive Symptoms in Adults Aged 18-65 Years With a Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

TypeinterventionalSponsorRochester Center for Behavioral MedicineRan2021 to 2024Enrolled44ConditionsChronic Fatigue Syndrome, Myalgic EncephalomyelitisArmsSolriamfetol Oral Tablet [Sunosi], Placebo
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Systematic review of the multidimensional fatigue symptom inventory-short form.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2015
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Randomized pilot trial of yoga versus strengthening exercises in breast cancer survivors with cancer-related fatigue.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Trial
  8. Trial
  9. Cancer-related intrusive thoughts predict behavioral symptoms following breast cancer treatment.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2014
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Work Productivity Among Younger Breast Cancer Survivors: The Impact of Behavioral Interventions for Depression.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kristine A DonovanHealth Outcomes and Behavior Program, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, MRC-PSY, Tampa, FL 33612, USA. kristine.donovan@moffitt.org
Paul B Jacobsen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeFatigue is one of the most common symptoms experienced by persons with chronic illness, including cancer. The effective management of fatigue hinges in part on the accuracy and reliability of its measurement. The purpose of this study was to review and characterize the use of the 14-item Fatigue Symptom Inventory (FSI) in published studies and to evaluate the available evidence for its psychometric properties.

methodsA systematic review of the literature identified 55 studies reporting results for the FSI. Data were analyzed to characterize internal consistency reliability of multi-item FSI scales and test-retest reliability. Correlation coefficients were summarized to characterize concurrent, convergent, and divergent validity. Standardized effect sizes were calculated to characterize the discriminative validity of the FSI and its sensitivity to change.

resultsSample sizes across studies ranged from 9-1,756. Approximately half of the samples consisted exclusively of females. Alpha coefficients for multi-item scales ranged from 0.84-0.96. Most items demonstrated low to moderate test-retest correlations. Correlations with other fatigue measures ranged from 0.41-0.86. Correlations with depression and anxiety measures were positive (range = 0.23-0.76). Correlations with measures of vitality and vigor were negative (range = -0.28 to -0.77). Effect sizes for discriminative validity and sensitivity to change ranged from small to medium and from small to large, respectively.

conclusionsFindings provide good empirical evidence of the usefulness of the FSI and strongly support its use in future studies.

Indexed as

FatigueFemaleHumansMaleNeoplasmsPsychometricsReproducibility of ResultsSelf ReportSeverity of Illness Index

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.